Researchers have identified high expression of CTSB in human pancreatic ductal adenocarcinomas and pancreatic cancer stem cells, and demonstrated its association with poor survival and surgical outcomes (44, 45). This evidence concerns the gene CTSB and pancreatic neoplasm.